跳至主要内容
临床试验/JPRN-UMIN000001153
JPRN-UMIN000001153未知3 期

Randomized control trial on efficacy of transcatheter arterial chemoembolization with cisplatin-lipiodol suspension or epirubicin-lipiodol emulsion for hepatocellular carcinoma. - Randomized control trial on efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma.

Department of Gastroenterology and Hepatology, Okayama University Graguate School of Medicine, Dentistry and Pharmaceutical Sciences.0 个研究点目标入组 360 人开始时间: 2008年5月20日最近更新:
适应症

试验速览

阶段
3 期
发起方
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Active double cancers. 2. Severe complications (excluding chronic hepatitis and liver cirrhosis). 3. Cardiomyopathy , congestive heart failure or medical history of them. 4. Total dose limiting of anticancer drugs with cardiac toxicity, ex. anthracyclin. 5. Medical history of severe hypersensitivity. 6. Pregnant, lactating women or women with suspected pregnancy. 7. Inappropriate patients for this study judged by the physicians.

研究者

发起方
Department of Gastroenterology and Hepatology, Okayama University Graguate School of Medicine, Dentistry and Pharmaceutical Sciences.

相似试验